Image credit: Topsy.one
Maria Fernanda Guanipa on 04th Jun

Lynparza could avoid chemotherapy in breast cancer patients

Lynparza, a drug developed by AstraZeneca, can help slow down the progression of advanced breast cancer, according to a...

Read More
Asthma attack
Daniel Francis on 08th Sep

Benralizumab may effectively treat severe asthma flare-ups

A new drug called Benralizumab showed promising results in reducing asthma attacks that cannot be prevented or treated by...

Read More
Daniel Contreras on 18th May

AstraZeneca’s Lynparza did not achieve ‘statistical significance’ in patients

AstraZeneca plc (NYSE: AZN) combination drug for gastric cancer did not achieve “statistical significance” in patients....

Read More
Melany Mejias on 23rd Mar

AstraZeneca heart drug proved not better than aspirin

AstraZeneca’s heart drug Brilinta failed to work as hoped in key stroke trial. The British drug maker said on Wednesday...

Read More
Emmanuel Ferreira on 14th Nov

FDA’s approval for Tagrisso, AstraZeneca’s $3 billion lung cancer drug

A new lung cancer treatment from the British company AstraZeneca PLC (LON: AZN) received the early approval of the U.S. Food...

Read More
Emmanuel Ferreira on 16th Oct

FDA asks for more clinical trials to AstraZeneca diabetes treatment

AstraZeneca Plc. (LON: AZN) failed to obtain U.S. approval from the FDA for a new treatment for diabetes. Regulators...

Read More
Daniel Contreras on 05th Sep

FDA approves AstraZeneca’s Brilinta treatment for heart disease

Washington – The pharmaceutical company AstraZeneca (NYSE:AZN) has seen its efforts rewarded when as a result of a large-scale...

Read More